Bronchiolitis Obliterans Syndrome

• Site 506 — Klagenfurt, Austria
• Site 503 — Senftenberg, Austria
• Site 501 — Vienna, Austria
• Site 502 — Vienna, Austria

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Bakersfield, California, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Santa Monica, California, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Miami, Florida, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Miramar, Florida, United States

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Bakersfield, California, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — New Haven, Connecticut, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Washington D.C., District of Columbia, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Miami, Florida, United States

• Nucleus Network, Austin Hospital — Heidelberg, Victoria, Australia
• Nucleus Network, The Alfred Hospital — Melbourne, Victoria, Australia
• Linear Clinical Research, The Queen Elizabeth II Medical Centre — Nedlands, Western Australia, Australia
• Primorus Clinical Trials Ltd — Christchurch, New Zealand

• Novartis Investigative Site — Ōbu, Aichi-ken, Japan
• Novartis Investigative Site — Chiba, Japan
• Novartis Investigative Site — Kanazawa, Ishikawa-ken, Japan
• Novartis Investigative Site — Kagoshima, Kagoshima-ken, Japan

• Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine — Seoul, South Korea

• Mile High Research Center — Denver, Colorado, United States
• The New England Center for Headache — Stamford, Connecticut, United States
• Walton Rehabilitation Hospital — Augusta, Georgia, United States
• Rush Pain Center — Chicago, Illinois, United States

• Wooridul Spine Hospital — Seoul, South Korea

Not specified

• Respiratory Medicine, Clinical trials Unit, Castle Hill Hospital — Cottingham, East Yorkshire, United Kingdom